Whitehead

Showing 15 posts of 22 posts found.

Kearney image

New president for ABPI

February 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Amgen, Pfizer, Whitehead, emms, john kearney

The Association of the British Pharmaceutical Industry has appointed John Kearney as its new president. Stepping into the role in …

Ian Goldin, director, Oxford Martin School, University of Oxford speaks at the c

Visions for the future: FT pharma and biotech event

December 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, ABPI, Deloitte, Medidata, Whitehead, financial ties, freeman, ft pharma

The FT Global Pharmaceutical and Biotechnology Conference held in London recently asked: “What will the life science company of the …

ABPI image

PPRS scheme payment percentage to rise by 6.62% in 2015

December 12, 2014
Sales and Marketing ABPI, PPRS, VBP, Whitehead, government, medicines bill

The amount of payment due from pharma via the PPRS scheme for next year has been confirmed by the Department …

andy-powrie-smith

ABPI director jumps ship to EFPIA

December 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, Whitehead, andrew powrie-smith, andrew-powrie-smith

ABPI director Andrew Powrie-Smith is leaving the body to join The European Federation of Pharmaceutical Industries and Associations (EFPIA) as …

Osborne and co image

UK budget sees R&D tax credits rise

December 3, 2014
Sales and Marketing Budget, Cameron, George Osborne, NHS, Whitehead, life sciences

Chancellor George Osborne has delivered the government’s 2014 Autumn Statement to the Commons which includes news of an increase in …

NICE releases ‘person-centred’ medicines optimisation guidelines

October 14, 2014
Research and Development, Sales and Marketing ABPI, NHS, NICE, UK, WHO, Whitehead

NICE has recently released the draft of its first guidance on medicines optimisation that it hopes will be more person-centered …

ABPI image

ABPI and BIA establish new manufacturing partnership

September 23, 2014
Manufacturing and Production, Sales and Marketing ABPI, Actavis, AstraZeneca, BIA, Eisai, Fujifilm Diosynth Biotechnologies, GlaxoSmithKline, Knowledge Transfer Network (KTN), Oxford BioMedica, Pfizer, Whitehead, bates, mmip

The ABPI and the Bioindustry Association (BIA) have jointly established a new Medicines Manufacturing Industry Partnership (MMIP) to boost medicines …

deepak_khanna_web__abpi

Deepak Khanna: the legacy of an outgoing ABPI president

March 31, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Deepak Khanna, NHS, VBP, Whitehead, apbi, jonathan emms

You’d be forgiven for thinking that Deepak Khanna, the man who has overseen the activities of the ABPI for the …

abpi image

ABPI: NHS must explain drugs take-up

January 22, 2014
Sales and Marketing ABPI, NHS, NICE, Whitehead

The ABPI has called on the NHS to explain what it says is the ‘substantial variation’ in NHS patients’ access …

Jonathan Emms

Pfizer head to be ABPI president

December 4, 2013
Medical Communications, Sales and Marketing ABPI, MSD, PPRS, Pfizer, Whitehead, emms, khanna

The UK managing director of Pfizer Jonathan Emms is to replace Deepak Khanna as the ABPI president from April next …

meaden

New ABPI director of communications announced

June 17, 2013
Medical Communications, Research and Development, Sales and Marketing ABPI, Meadden, Whitehead

The ABPI has appointed its head of Policy and Public Affairs Catherine Meaden to be the organisation’s new director of …

abpi_reception

‘No consensus’ on transparency

April 22, 2013
Medical Communications, Research and Development, Sales and Marketing ABPI, Goldacre, Whitehead, all trials, transparency

An ABPI meeting on increasing the transparency of the way clinical trials are reported has thrown up more questions than …

bad pharma image

Ben Goldacre versus Stephen Whitehead – PharmaTimes Debate

February 27, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BMJ, Bad pharma, Cochrane, Goldacre, Whitehead

In the end, the ‘head to head’ between the UK’s most high profile critic of the pharma industry and ABPI …

NICE image

NICE hits back at ‘limited’ EC study

January 28, 2013
Sales and Marketing ABPI, EC, NHS, NICE, QALY, Whitehead

NICE has delivered a robust defence of the methods by which it arrives at a judgment on the value of …

The Gateway to Local Adoption Series

Latest content